SCHEMBL23237226

SCHEMBL23237226

c1cc(-c2ccc(N(c3ccc(-c4cccc5c4sc4ccccc45)cc3)c3ccc(-c4cccc5oc6ccccc6c45)cc3)cc2)cc(-c2cccc3ccccc23)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 1/20 0.43
▸ PRKDC P78527 5/20 0.38
▸ CA12 O43570 3/20 0.35
▸ CA1 P00915 3/20 0.35
▸ CA2 P00918 3/20 0.35
▸ CA9 Q16790 3/20 0.35
▸ PLA2G2A P14555 1/20 0.32
▸ PLA2G4A P47712 1/20 0.32
▸ F9 P00740 1/20 0.32
▸ PIK3CD O00329 2/20 0.31
▸ PIK3CB P42338 2/20 0.31
▸ BRD4 O60885 1/20 0.31
▸ PIK3CA P42336 1/20 0.31
▸ MTOR P42345 1/20 0.31
▸ PIK3CG P48736 1/20 0.31
▸ KCNH2 Q12809 1/20 0.31
▸ BRDT Q58F21 1/20 0.31
▸ PARP14 Q460N5 1/20 0.30
▸ LIMK1 P53667 1/20 0.30
▸ S1PR4 O95977 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25534828 0.96 ALOX5 (0.42) ALOX5PRKDCCA12CA1CA2
SCHEMBL25824682 0.96 ALOX5 (0.42) ALOX5PRKDCCA12CA1CA2
SCHEMBL25535585 0.96 ALOX5 (0.42) ALOX5PRKDCCA12CA1CA2
SCHEMBL25534810 0.96 ALOX5 (0.42) ALOX5PRKDCCA12CA1CA2
SCHEMBL24710228 0.95 ALOX5 (0.47) ALOX5PRKDCPLA2G2APLA2G4AF9
SCHEMBL23224820 0.94 ALOX5 (0.43) ALOX5PRKDCCA12CA1CA2
SCHEMBL25535579 0.94 ALOX5 (0.43) ALOX5PRKDCCA12CA1CA2
SCHEMBL25534658 0.94 ALOX5 (0.43) ALOX5PRKDCCA12CA1CA2
SCHEMBL25534676 0.94 ALOX5 (0.43) ALOX5PRKDCCA12CA1CA2
SCHEMBL23238815 0.92 ALOX5 (0.42) ALOX5PRKDCCA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230227397-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-07-20 — — US disclosed
US-20230227397-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-07-20 — — US disclosed
WO-2021070964-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE 出光興産株式会社 2021-04-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230227397-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE LEF1, PIEZO1, ELAVL1 ALOX5 1352/4885PRKDC 4563/4885CA12 2251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback